Skip to content

Drug interactions

Ceritinib + Dipyridamole

Severity: Moderate

Ceritinib and Dipyridamole: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dipyridamole may inhibit P-glycoprotein and raise ceritinib exposure, increasing its gastrointestinal, hepatic and QT-related adverse effects. The effect is predicted rather than well characterized.

What this interaction means in plain words

Ceritinib and Dipyridamole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ceritinib belongs to Oncology; Dipyridamole belongs to Cardiovascular.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by dipyridamole may reduce efflux of ceritinib and increase its exposure.

What to do

Monitor for ceritinib toxicity including liver enzymes, ECG and gastrointestinal symptoms, and reduce the dose if adverse effects emerge.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ceritinib and Dipyridamole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ceritinib with Dipyridamole?

MediHelp rates the interaction as moderate. Ceritinib and Dipyridamole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dipyridamole may inhibit P-glycoprotein and raise ceritinib exposure, increasing its gastrointestinal, hepatic and QT-related adverse effects. The effect is predicted rather than well characterized.

How serious is the interaction between Ceritinib and Dipyridamole?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ceritinib toxicity including liver enzymes, ECG and gastrointestinal symptoms, and reduce the dose if adverse effects emerge.

What other medicines interact with Dipyridamole?

MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in